STAT+: No more waffling: Belgium discloses penalties for failing to report clinical trial results

In the latest move to crack down on wayward clinical trial sponsors, Belgium may now fine companies, hospitals, and universities that fail to publicly disclose study results, a sign that more European regulators are growing concerned about a lack of transparency surrounding medical data.
As of this month, the Federal Agency for Medicines and Health Products can impose fines of $550 to $280,000 and threaten imprisonment of up to two years. The penalties, set forth in a 2017 law,  did not go into effect for trial results until now because they were tied to European Union regulations that began in January . However, a new remedy adopted by the agency would permit violators to reach a settlement of at least $4,500 or otherwise face further proceedings, an FAMHP spokesperson explained. Continue to STAT+ to read the full story…